[Biological changes during the local administration of small doses of urokinase].
D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D010450:Endopeptidases / Q000627:therapeutic use*; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D006801:Humans; D010958:Plasminogen / Q000032:analysis; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*
D005338:Fibrin Fibrinogen Degradation Products; D005340:Fibrinogen; D010958:Plasminogen; D010450:Endopeptidases; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator
Modifications biologiques au cours de l'administration locale de faibles doses d'urokinase.